Ammonia volatilization and yield components after application of polymer-coated urea to maize

A form of increasing the efficiency of N fertilizer is by coating urea with polymers to reduce ammonia volatilization. The aim of this study was to evaluate the effect of polymer-coated urea on the control of ammonia volatilization, yield and nutritional characteristics of maize. The experiment was carried out during one maize growing cycle in 2009/10 on a Geric Ferralsol, inUberlândia, MG, Brazil. Nitrogen fertilizers were applied as topdressing on the soil surface in the following urea treatments: polymer-coated urea at rates of 45, 67.5 and 90 kg ha-1 N and one control treatment (no N), in randomized blocks with four replications. Nitrogen application had a favorable effect on N concentrations in leaves and grains, Soil Plant Analysis Development (SPAD) chlorophyll meter readings and on grain yield, where as coated urea had no effect on the volatilization rates, SPAD readings and N leaf and grain concentration, nor on grain yield in comparison to conventional fertilization.

Augmentation of bone defect healing using a new biocomposite scaffold: an in vivo study in sheep.

Previous studies support resorbable biocomposites made of poly(L-lactic acid) (PLA) and beta-tricalcium phosphate (TCP) produced by supercritical gas foaming as a suitable scaffold for tissue engineering. The present study was undertaken to demonstrate the biocompatibility and osteoconductive properties of such a scaffold in a large animal cancellous bone model. The biocomposite (PLA/TCP) was compared with a currently used beta-TCP bone substitute (ChronOS, Dr. Robert Mathys Foundation), representing a positive control, and empty defects, representing a negative control. Ten defects were created in sheep cancellous bone, three in the distal femur and two in the proximal tibia of each hind limb, with diameters of 5 mm and depths of 15 mm. New bone in-growth (osteoconductivity) and biocompatibility were evaluated using microcomputed tomography and histology at 2, 4 and 12 months after surgery. The in vivo study was validated by the positive control (good bone formation with ChronOS) and the negative control (no healing with the empty defect). A major finding of this study was incorporation of the biocomposite in bone after 12 months. Bone in-growth was observed in the biocomposite scaffold, including its central part. Despite initial fibrous tissue formation observed at 2 and 4 months, but not at 12 months, this initial fibrous tissue does not preclude long-term application of the biocomposite, as demonstrated by its osteointegration after 12 months, as well as the absence of chronic or long-term inflammation at this time point.